Mantara Health is a pharmacogenomics (PGx) company founded by doctors. Its mission is to personalize medical treatment by using DNA testing to guide medication prescriptions. The company aims to eliminate the trial-and-error approach in healthcare by providing evidence-based, medical-grade genetic testing that enables doctors to choose the most effective medications and dosages for each individual patient based on their unique genetic makeup.
Mantara Products and Service Information
The core product is the Mantara PGx DNA Test, a pharmacogenomic panel that analyzes 12 key genes to predict an individual’s response to 77+ different medications. This includes drugs for conditions like high cholesterol, anxiety, depression, acid reflux, and stroke prevention. They also offer a Rapid Clopidogrel Genetic Test, a faster, targeted test for a specific stroke-prevention medication. The service is designed to be used through healthcare professionals—patients or clinicians order the test kit, a DNA sample is collected via a cheek swab and mailed to their lab, and a detailed report is sent to the prescribing doctor to inform treatment decisions. The tests are CE & UKCA marked and approved by the UK’s MHRA.
Mantara Review (Positioning & Testimonials)
The website does not host public star ratings but features powerful patient testimonials that highlight the real-world impact of the service. Individuals report transformative results, such as finally finding an effective antidepressant without side effects or significantly improving their quality of life after a medication change informed by their genetic results. The company’s credibility is strongly established by being featured in The Lancet, following 2024 NICE (UK National Institute for Health and Care Excellence) guidance, and by highlighting compelling industry statistics (e.g., 90% of medications are only effective for 30-50% of people). It positions itself as an award-winning, clinical-grade tool to make prescribing safer and more effective.
